Business - n.a.

Intercell Does Not Leave the Loss zone

Published: March 6, 2012; 13:02 · (Vindobona)

The Austrian pharmaceutical company announces preliminary full year 2011 financial results. Losses totaled € 29m.

Intercell Does Not Leave the Loss zone / Picture: © Intercell

Intercell noted total revenues of € 32.9m in 2011 compared to € 34.2m in 2010, which is due to lower collaboration revenues. In the last quarter of 2011, revenues reached € 6.98m, after € 13.1m in 2010. The company decided to reduce R&D expenses by 60.0% to € 29.9m and SG&A expenses by 20.1% to € 15.8m.

Net loss reached € 29.3m in the year 2011, compared to…

This article includes a total of 106 words.

or Log In

Fast News Search

Join us to succeed in Vienna! Sign up to read articles for free and to get personalized updates on the events that interest you.

Intercell Does Not Leave the Loss zone

The Austrian pharmaceutical company announces preliminary full year 2011 financial results. Losses totaled € 29m.

Join us to succeed in Vienna!
Sign up to read articles for free and to get personalized updates on the events that interest you.